Attached files
| file | filename |
|---|---|
| 10-Q - Tongli Pharmaceuticals (USA), Inc. | v193826_10q.htm |
| EX-31.1 - Tongli Pharmaceuticals (USA), Inc. | v193826_ex31-1.htm |
| EX-32.1 - Tongli Pharmaceuticals (USA), Inc. | v193826_ex32-1.htm |
| EX-31.2 - Tongli Pharmaceuticals (USA), Inc. | v193826_ex31-2.htm |
Exhibit
32.2
CERTIFICATION
OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C.
SECTION
1350
In
connection with the accompanying Quarterly Report on Form 10-Q of Tongli
Pharmaceuticals (USA), Inc. for the period ended June 30, 2010, I, Li Li, Chief
Financial Officer, hereby certifies pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
1. Such
Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, fully
complies with the requirements of section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
2. The
information contained in such Quarterly Report on Form 10-Q for the quarter
ended June 30, 2010, fairly presents, in all material respects, the financial
condition and results of operations of Tongli Pharmaceuticals (USA),
Inc.
Dated:
August 16, 2010
|
/s/
Li Li
|
|
|
Li
Li
|
|
|
Chief
Financial Officer
|